The White House is considering changes to the leadership of the Food and Drug Administration, according to recent reports.

Reuters reports that the administration is considering naming the FDA's current food chief as acting commissioner, suggesting a potential reshuffling of the agency's top positions.

Separately, the Wall Street Journal indicates that President Trump is prepared to remove the current FDA commissioner from the position.

The FDA plays a critical role in regulating food, drugs, medical devices, and other consumer products in the United States. Leadership changes at the agency can have significant implications for regulatory policy and public health initiatives.

The timing and specific details of any potential changes remain unclear, as neither the White House nor the FDA have officially confirmed the reported considerations for new leadership appointments.